0001140361-20-024925.txt : 20201106
0001140361-20-024925.hdr.sgml : 20201106
20201106181908
ACCESSION NUMBER: 0001140361-20-024925
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201103
FILED AS OF DATE: 20201106
DATE AS OF CHANGE: 20201106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRAWLEY OTIS W
CENTRAL INDEX KEY: 0001213029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 201295557
MAIL ADDRESS:
STREET 1: 5203 BRISTOL INDUSTRIAL WAY
CITY: BUFORD
STATE: GA
ZIP: 30518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25B VREELAND ROAD
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 25B VREELAND ROAD
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
FORM 4
X0306
4
2020-11-03
0001472091
PDS Biotechnology Corp
PDSB
0001213029
BRAWLEY OTIS W
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD
FLORHAM PARK
NJ
07932
true
Stock Option (Right to Buy)
2.09
2020-11-03
4
A
0
9000
0
A
2030-11-03
Common Stock
9000
9000
D
One-third (1/3) of the shares underlying the option shall vest upon each of the first, second and third anniversaries of the date of grant, such that the option will be fully vested on November 3, 2023.
/s/ Otis Brawley, M.D.
2020-11-06